Trial intelligence / Profile preview

Preoperative mirtazapine for reduction of postoperative pain

IRCT20221015056178N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in postoperative pain comparing Mirtazapine with Placebo B-complex (2 arms). Primary endpoints: Pain severity at 2 hours after leaving the operating room, Pain severity at 6 hours after leaving the operating room and 1 more. Started Aug 2023; status: completed.

02

Drugs

mirtazapine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20221015056178N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221015056178N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call